Kindstar Globalgene Technology, Inc. (Kindstar Global) filed its Monthly Return for the period ended 31 July 2026, detailing fresh treasury share activity and an unchanged authorised share base.

Share repurchase programme • Between 2 July and 27 July, the company repurchased 1.20 million ordinary shares on-market at an average HK$0.97 per share, for a total consideration of about HK$1.16 million. • All repurchased shares were retained as treasury stock.

Capital structure after the transactions • Issued shares (excluding treasury): 1,032.68 million, down by 1.20 million from the previous month. • Treasury shares: 8.64 million, up by the same amount. • Total issued share count remained unchanged at 1,041.33 million. • Authorised share capital held steady at 2.00 billion ordinary shares with an aggregate par value of USD0.50 million.

Equity incentive schemes • Pre-IPO stock incentive plans: 2.63 million options outstanding; no exercises during the month. • Post-IPO share option scheme: 50,000 options outstanding; the scheme still allows for up to 67.87 million additional share grants. • No proceeds were raised from option exercises in July.

Regulatory compliance • The company confirmed that its public float remained above the 25% threshold required under the Hong Kong Listing Rules at month-end.

The disclosures signal continued utilisation of the authorised share buy-back mandate without altering the overall share count, while maintaining full compliance with listing and regulatory obligations.